- Type / Class
- Equity / Common Stock
- Shares outstanding
- 235,704,040
- Total 13F shares
- 210,797,270
- Share change
- +4,907,782
- Total reported value
- $3,837,973,056
- Put/Call ratio
- 75%
- Price per share
- $18.21
- Number of holders
- 367
- Value change
- +$78,904,738
- Number of buys
- 230
- Number of sells
- 161
Quarterly Holders Quick Answers
What is CUSIP 000899104?
CUSIP 000899104 identifies ADMA - ADMA BIOLOGICS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 000899104:
Top shareholders of ADMA - ADMA BIOLOGICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13D/G
13F
|
Company |
15%
|
35,907,601
|
$865,732,260 | $0 | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
7.1%
|
16,841,449
|
$334,134,349 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
5.5%
|
12,866,904
|
$255,279,375 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
13D/G
|
Company · STATE STREET CORPORATION |
5.1%
from 13D/G
|
11,440,778
|
$226,985,036 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
5,667,812
|
$112,474,829 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
2.1%
|
4,913,928
|
$97,492,331 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2.1%
|
4,860,314
|
$96,434,295 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
2%
|
4,714,861
|
$93,542,842 | — | 31 Mar 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
1.8%
|
4,252,362
|
$84,366,884 | — | 31 Mar 2025 | |
| Perpetual Ltd |
13F
|
Company |
1.5%
|
3,551,813
|
$70,467,970 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.5%
|
3,548,988
|
$70,411,922 | — | 31 Mar 2025 | |
| OBERWEIS ASSET MANAGEMENT INC/ |
13F
|
Company |
1.5%
|
3,426,260
|
$67,976,998 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
1.4%
|
3,364,995
|
$66,761,493 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
1.4%
|
3,363,639
|
$66,734,598 | — | 31 Mar 2025 | |
| PERCEPTIVE ADVISORS LLC |
3/4/5
13F
|
10%+ Owner · Company |
0.58%
from 13F
|
13,262,375
|
$59,945,935 | — | 28 Sep 2021 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
1.3%
|
3,048,946
|
$59,210,531 | — | 31 Mar 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.3%
|
2,946,570
|
$58,459,949 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
1.2%
|
2,816,814
|
$55,885,590 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.1%
|
2,594,756
|
$51,479,958 | — | 31 Mar 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
1.1%
|
2,586,600
|
$51,318,144 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1%
|
2,462,005
|
$48,846,179 | — | 31 Mar 2025 | |
| AWM Investment Company, Inc. |
13F
|
Company |
1%
|
2,426,431
|
$48,140,391 | — | 31 Mar 2025 | |
| B Group, Inc. |
13F
|
Company |
0.98%
|
2,317,542
|
$45,980,033 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.96%
|
2,255,306
|
$44,745,271 | — | 31 Mar 2025 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.95%
|
2,241,623
|
$44,474,000 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.91%
|
2,146,309
|
$42,582,771 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.9%
|
2,110,931
|
$41,881,000 | — | 31 Mar 2025 | |
| THRIVENT FINANCIAL FOR LUTHERANS |
13F
|
Company |
0.79%
|
1,861,501
|
$36,932,000 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.75%
|
1,771,459
|
$35,145,746 | — | 31 Mar 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.69%
|
1,633,730
|
$32,413,203 | — | 31 Mar 2025 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.69%
|
1,632,675
|
$32,392,277 | — | 31 Mar 2025 | |
| Ranger Investment Management, L.P. |
13F
|
Company |
0.68%
|
1,603,510
|
$31,813,638 | — | 31 Mar 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.65%
|
1,525,527
|
$30,266,456 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.62%
|
1,468,609
|
$29,137,212 | — | 31 Mar 2025 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.61%
|
1,446,390
|
$28,696,000 | — | 31 Mar 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.56%
|
1,319,803
|
$26,185,619 | — | 31 Mar 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.55%
|
1,288,121
|
$25,556,321 | — | 31 Mar 2025 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.51%
|
1,204,127
|
$23,889,880 | — | 31 Mar 2025 | |
| Ophir Asset Management Pty Ltd |
13F
|
Company |
0.49%
|
1,161,339
|
$23,040,966 | — | 31 Mar 2025 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.47%
|
1,116,059
|
$22,142,611 | — | 31 Mar 2025 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.47%
|
1,108,911
|
$22,000,794 | — | 31 Mar 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.45%
|
1,050,000
|
$20,832,000 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.43%
|
1,001,852
|
$19,876,743 | — | 31 Mar 2025 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.37%
|
874,603
|
$17,352,124 | — | 31 Mar 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.36%
|
847,558
|
$16,815,551 | — | 31 Mar 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.35%
|
816,590
|
$16,201,145 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.33%
|
782,194
|
$15,518,728 | — | 31 Mar 2025 | |
| PUBLIC SECTOR PENSION INVESTMENT BOARD |
13F
|
Company |
0.32%
|
749,702
|
$14,874,088 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.3%
|
701,775
|
$13,923,216 | — | 31 Mar 2025 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.3%
|
697,001
|
$13,828,500 | — | 31 Mar 2025 |
Institutional Holders of ADMA BIOLOGICS, INC. - Common Stock (ADMA) as of Q2 2025
As of 30 Jun 2025,
ADMA BIOLOGICS, INC. - Common Stock (ADMA) was held by
367 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
210,797,270 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, Invesco Ltd., STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, Nuveen, LLC, DIMENSIONAL FUND ADVISORS LP, AMERICAN CENTURY COMPANIES INC, Allspring Global Investments Holdings, LLC, and Thrivent Financial for Lutherans.
This page lists
365
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
342
Q2 2025 holders
367
Holder diff
25
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.